Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Stock Market News Updates

Stock Market Investment Shot, 20th January 2023

by Sumit Chanda
January 20, 2023
in Stock Market News Updates
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

Vedanta approved the sale of its global zinc assets in South Africa and Namibia to Hindustan Zinc (HZL) for $2.98 billion. HZL is a subsidiary of Vedanta Ltd. The transaction would be completed over the next 18 months, subject to regulatory clearances. HZL had also reported a 20% yoy fall in net profits at Rs2,156 crore, while the revenues fell 2% to Rs7,628 crore. Integrated zinc output fell 1.&% to 210 KT due to the shortage of quality ores. Silver production dropped 7% to 161 KT. Zinc saw cost of production rise 12.7%.

Sun Pharma bought NASDAQ listed Concert Pharmaceuticals for $576 million. Concert Pharma is a biotech company, that manufactures deuruxolitinib, an oral treatment for autoimmune dermatological disease in late-stage development. The deal size is around $827 million if additional milestone payments are added. The transaction will be completed in the first quarter of 2023. The US market accounts for 30% of Sun Pharma’s consolidated business and it ranks second in dermatological prescriptions for various ailments.

The current account deficit (CAD) is expected to reduce in 2023 from inflation being brought back inside the tolerance band. In Q2FY3, the current account had touched 4.4% of GDP and a record absolute level of $36.4 billion. With CPI inflation falling to 5.7% in December, it is clear that imported inflation is under check, although core inflation still remains an issue. GDP growth for FY23 has been pegged by the RBI at 6.8%. The RBI had raised the repo rates by 225 basis points during 2022 to bring inflation under control.

Asian Paints reported 6.4% higher net profits at Rs1,097 crore for the quarter ended December 2022. The revenues for the Q3FY23 quarter came in 1.3% higher at 8,637 crore. Volumes were flat in the domestic decorative business. Retail paint market was also impacted by the extended monsoon. However, the paint demand from the industrial segment had picked up sharply during the quarter. Its sales to Sri Lanka and Bangladesh got impacted by adverse forex conditions. Most paint companies have faced input pressure.

Indians are sending money abroad like there was no tomorrow sending out $2 billion in November under the liberalised remittance scheme (LRS) of the RBI. On a yoy basis, the outward remittances under LRS were higher by 29%. More than 50% of the outwards remittances were accounted for by global travel with airlines getting back into full action and business and private travel picking up with a vengeance. The other major reasons for remittances were maintenance of relatives, gifts and overseas education costs.

Microsoft will invest Rs16,000 crore for setting up 3 additional data centres in Hyderabad, taking the total proposed data centres to six. Each of the 6 data centres will have capacity of 100 MW of IT load. This would be part of the Azur infrastructure to serve the cloud customers in India. Microsoft is one of the key players in the data centres business in India and Hyderabad has been one of their preferred hubs in India. Apart from data centres, Microsoft will also work with the state to identify special projects to support.

Hindustan Unilever standalone net profits for Q3FY23 were up 11.6% yoy at Rs2,505 crore, marginally higher than the consensus estimates. There was higher  demand for its beauty and personal care products. Net revenues for the quarter grew 16% at Rs14,986 crore for the quarter. Over 75% of the business gained market share in the quarter. EBITDA margins of HUL dipped 180 bps yoy to 23.6%. Home Care clocked 32% revenue growth, Beauty and Personal Care rose 10% and Foods and Refreshment grew 7% in Q3FY23.

Supreme Court refused to entertain Google’s plea against NCLAT order virtually refusing interim stay on the Rs1,337 crore penalty case. Google has one week to comply with the NCLAT order and deposit 10% of the penalty amount. The order was passed by CCI for anti-competitive policies followed by Android. The ASG had argued that Google had complied with a similar order passed by the European Commission. Google has also been asked to stop and desist from involving itself in anti-competitive practices in future.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Jarvis Invest

India's AI-powered, SEBI-registered investment advisory — research, portfolios and global market intelligence for every investor.

Company

  • About Us
  • FAQs
  • Contact Us
  • Become a Partner

Products

  • Jarvis Portfolio
  • Jarvis Protect
  • Jarvis OneStock
  • Jarvis Prime
  • Sentiment Tracker (F&O)
  • US Multi-Asset Portfolio

Explore Topics

  • Equity Markets
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Financial Planning
  • Portfolio Management
  • Stock Market News Updates
  • Global Stock Market

Get in touch

Customer support customersupport@jarvisinvest.com

Jarvis Invest — SEBI Registered Investment Adviser (Reg. No. INA000013235) & SEBI Registered Research Analyst (Reg. No. INH000018762). Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© 2026 Jarvis Invest. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Categories
Equity MarketsGet latest insights on the Indian equity market including stock trends, market analysis, sector…Investing BasicsLearn stock market basics including investing fundamentals, equity concepts, and beginner-friendly guides to start…AI for investingStay ahead with AI-powered stock insights, trend analysis, and intelligent investing strategies for ai…Trending Stock Market News: Quick ReadsDiscover the latest trends in the stock market with insightful blogs from Jarvis Invest…Portfolio ManagementExpert insights on portfolio management, asset allocation, risk management, and strategies to optimise best…Stock Market News UpdatesGet daily stock market news updates, key market movements, and insights that matter to…Global Stock MarketGet latest global stock market news, trends, and AI-driven stock insights on US, Europe…Stock AdvisoryLearn how AI-powered stock advisory and expert market research can help you build wealth.
I Am A
BeginnerBeginner-friendly stock market guides covering investing basics, common mistakes, and simple strategies to build…IntermediateIntermediate-level stock market insights covering investment strategies, portfolio analysis, and market concepts for informed…
Products
Jarvis PortfolioModel portfolio matched to your risk profile for long-term wealth creation.Jarvis ProtectContinuous portfolio monitoring for your existing portfolio with timely sell alerts to help manage downside risk.Jarvis OneStockHigh-conviction stock recommendations designed for short-term investing.Jarvis Prime - For HNIs & UHNIsPremium portfolio management services for investors with ₹25 lakh+ investment corpus.Jarvis Sentiment Tracker - AI Tool for F&OReal-time market sentiment analysis and trading signals for options traders.Jarvis US Multi-Asset PortfolioDiversified US portfolio investing across stocks and ETFs with automated portfolio management.Jarvis AtlasInvestment opportunities across Indian equities, global markets, and commodities in 10+ global markets.
No Result
View All Result
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version